SCHEMBL2177829

SCHEMBL2177829

CNc1nccc(-c2cc(N)c3cc(OC)ccc3c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.50
TTK P33981 1/20 0.50
AURKB Q96GD4 1/20 0.50
INCENP Q9NQS7 1/20 0.50
CDK5 Q00535 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CDK5R1 Q15078 1/20 0.46
PIK3CG P48736 6/20 0.46
PIK3CA P42336 5/20 0.46
PIK3CB P42338 5/20 0.46
PDPK1 O15530 1/20 0.46
IKBKB O14920 2/20 0.43
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178130 0.82 PDPK1 (0.46) CDK5MEN1KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL2178319 0.81 PDPK1 (0.45) CDK5MEN1KMT2ANPC1RAB9A
SCHEMBL2177838 0.80 FERMT2 (0.44) CDK5MEN1KMT2ANPC1RAB9A
SCHEMBL2178148 0.80 HSD17B1 (0.46) CDK5NPC1RAB9ACDK5R1PIK3CG
SCHEMBL2176027 0.78 NCF1 (0.54) PIK3CGPIK3CAPIK3CBIKBKB
SCHEMBL2178230 0.78 HTR1A (0.43) CDK5MEN1KMT2ANPC1RAB9A
SCHEMBL2179083 0.78 MTOR (0.52) MEN1KMT2ANPC1RAB9A
SCHEMBL2178808 0.77 CASP2 (0.41) PIK3CGPIK3CAPIK3CBDYRK1ACLK4
Hydrochloric Acid SCHEMBL2177589 0.77 NCF1 (0.53) PIK3CGPIK3CAPIK3CBIKBKB
SCHEMBL2175891 0.77 HDAC3 (0.49) MEN1KMT2ANPC1RAB9APIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519519-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 EP disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP AURKA 876/4885TTK 2139/4885AURKB 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.